Incorporation of secretory immunoglobulin A into biofilms can decrease their resistance to ciprofloxacin

Microbiology and Immunology

Volumn 55, Issue 3, 2011, Pages 174-183

  Lee, Yu Huei ^a   Su, Kuei Ying ^a,d   Wyse, Aaron ^a   Barbas, Andrew ^a   Palestrandt, Daniel ^a   Shieh, Karl ^a   Lou Everett, Mary ^a   Devalapalli, Aditya ^a   Orndorff, Paul E ^c   Bollinger, R Randal ^a,b   Parker, William ^a  

^a Surgery   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Antibiotic; Ciprofloxacin; Escherichia coli; Host supported biofilms

Indexed keywords

CIPROFLOXACIN; SECRETORY IMMUNOGLOBULIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIOPLANKTON; BIOFILM; CONTROLLED STUDY; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; SYMBIOTIC BIOFILM;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CIPROFLOXACIN; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; IMMUNOGLOBULIN A, SECRETORY; MICE; MILK;

ANIMALIA; ESCHERICHIA COLI; MAMMALIA;

EID: 79951968125     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2010.00297.x     Document Type: Article

References (49)

1. Danhorn T., Fuqua C. (2007) Biofilm formation by plant-associated bacteria. Annu Rev Microbiol 61: 401-22.
2. Everett M.L., Palestrant D., Miller S.E., Bollinger R.B., Parker W. (2004) Immune exclusion and immune inclusion: a new model of host-bacterial interactions in the gut. Clin Appl Immunol Rev 5: 321-32.
3. Boettcher K.J., Ruby E.G. (1990) Depressed light emission by symbiotic Vibrio fischeri of the sepiolid squid Euprymna scolopes. J Bacteriol 172: 3701-06.
4. Darby C. (2008) Uniquely insidious: Yersinia pestis biofilms. Trends Microbiol 16: 158-64.
5. Smith H.F., Fisher R.E., Everett M.L., Thomas A.D., Bollinger R.B., Parker W. (2009) Comparative anatomy and phylogenetic distribution of the mammalian cecal appendix. J Evol Biol 22: 1984-99.
6. Parker W., Thomas A.D. (2010) Cultivation of epithelial-associated microbiota by the immune system. Future Microbiology 5: 1483-92.
7. Sonnenburg J.L., Angenent L.T., Gordon J.I. (2004) Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat Immunol 5: 569-73.
8. Everett M.L., Palestrant D., Miller S.E., Bollinger R.B., Parker W. (2004) Immune exclusion and immune inclusion: a new model of host-bacterial interactions in the gut. Clin Appl Immunol Rev 5: 321-32.
9. Normark B.H., Normark S. (2002) Evolution and spread of antibiotic resistance. J Intern Med 252: 91-106.
10. Singh R., Ray P., Das A., Sharma M. (2009) Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J Med Microbiol 58: 1067-73.
11. Donlan R.M., Costerton J.W. (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-93.
12. Stewart P.S., William Costerton J. (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358: 135-38.
13. Bollinger R.R., Barbas A.S., Bush E.L., Lin S.S., Parker W. (2007) Biofilms in the normal human large bowel: fact rather than fiction. Gut 56: 1481-82.
14. Bollinger R.R., Everett M.L., Palestrant D., Love S.D., Lin S.S., Parker W. (2003) Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology 109: 580-87.
15. Bollinger R.R., Everett M.L., Wahl S.D., Lee Y.-H., Orndorff P.E., Parker W. (2006) Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol Immunol 43: 378-87.
16. Forder R.E.A., Howarth G.S., Tivey D.R., Hughes R.J. (2007) Bacterial modulation of small intestinal goblet cells and mucin composition during early posthatch development of poultry. Poult Sci 86: 2396-403.
17. Friman V., Adlerberth I., Connell H., Svanborg C., Hanson L., Wold A. (1996) Decreased expression of mannose-specific adhesins by Escherichia coli in the colonic microflora of immunoglobulin A-deficient individuals. Infect Immun 64: 2794-98.
18. Kelly D., Conway S., Aminov R. (2005) Commensal gut bacteria: mechanisms of immune modulation. Trends Microbiol 26: 326-33.
19. Kleessen B., Blaut M. (2005) Modulation of gut mucosal biofilms. Br J Nutr 93: S35-S40.
20. Macfarlane S., Macfarlane G.T. (2006) Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut. Appl Environ Microbiol 72: 6204-11.
21. Macfarlane S., Woodmansey E.J., Macfarlane G.T. (2005) Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl Environ Microbiol 71: 7483-92.
22. Sonnenburg J.L., Angenent L.T., Gordon J.I. (2004) Getting a grip on things: how do communities of bacterial symbionts become established in our intestine Nat Immunol 5: 569-73.
23. Wold A.E., Adlerberth I. (2000) Breast feeding and the intestinal microflora of the infant -implications for protection against infectious diseases. Short and Long Term Effects of Breast Feeding on Child Health. Adv Exp Med Biol.
24. Orndorff P.E., Devapali A., Palestrant S., Wyse A., Everett M.L., Bollinger R.B., Parker W. (2004) Immunoglobulin-mediated agglutination and biofilm formation by Escherichia coli K-12 requires the type 1 pilus fiber. Infect Immun 72: 1929-38.
25. Bollinger R.B., Everett M.L., Wahl S., Lee Y.-H., Orndorff P.E., Parker W. (2005) Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol Immunol 43: 378-87.
26. Sherlock O., Schembri M.A., Reisner A., Klemm P. (2004) Novel Roles for the AIDA Adhesin from Diarrheagenic Escherichia coli: Cell Aggregation and Biofilm Formation. J Bacteriol 186: 8058-65.
27. Orndorff P.E., Devapali A., Palestrant S., Wyse A., Everett M.L., Bollinger R.R., Parker W. (2004) Immunoglobulin-mediated agglutination of and biofilm formation by Escherichia coli K-12 require the type 1 pilus fiber. Infect Immun 72: 1929-38.
28. Belley A., Neesham-Grenon E., Mckay G., Arhin F.F., Harris R., Beveridge T., Parr T.R. Jr., Moeck G. (2009) Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro. Antimicrob Agents Chemother 53: 918-25.
29. Ceri H., Olson M.E., Stremick C., Read R.R., Morck D., Buret A. (1999) The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37: 1771-76.
30. Conley J., Olson M.E., Cook L.S., Ceri H., Phan V., Davies H.D. (2003) Biofilm formation by Group A Streptococci: is there a relationship with treatment failure? J Clin Microbiol 41: 4043-48.
31. Shera J., Sriprakash K.S., Mcmillan D.J. (2006) The nutritional requirements for biofilm formation by Group A streptococcus. International Congress Series 1289: 139-42.
32. Rochex A., Godon J.-J., Bernet N., Escudié R. (2008) Role of shear stress on composition, diversity and dynamics of biofilm bacterial communities. Water Res 42: 4915-22.
33. Costerton J.W., Stewart P.S., Greenberg E.P. (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-22.
34. Donlan, Rodneym. (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33: 1387-92.
35. Karchmer A.W., Longworth D.L. (2003) Infections of intracardiac devices. Cardiol Clin 21: 253-71, vii.
36. Danese P.N. (2002) Antibiofilm approaches: prevention of catheter colonization. Chem Biol 9: 873-80.
37. Zimmerli W., Trampuz A., Ochsner P.E. (2004) Prosthetic-joint infections. N Engl J Med 351: 1645-54.
38. Braxton E., Ehrlich G., Hall-Stoodley L., Stoodley P., Veeh R., Fux C., Hu F., Quigley M., Post J. (2005) Role of biofilms in neurosurgical device-related infections. Neurosurg Rev 28: 249-55.
39. Conen A., Walti, Lauran., Merlo A., Fluckiger U., Battegay M., Trampuz A. (2008) Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin Infect Dis 47: 73-82.
40. Donelli G., Guaglianone E., Di Rosa R., Fiocca F., Basoli A. (2007) Plastic biliary stent occlusion: factors involved and possible preventive approaches. Clin Med Res 5: 53-60.
41. Swidsinski A., Schlien P., Pernthaler A., Gottschalk U., Bärlehner E., Decker G., Swidsinski S., Strassburg J., Loening-Baucke V., Hoffmann U., Seehofer D., Hale L.P., Lochs H. (2005) Bacterial biofilm within diseased pancreatic and biliary tracts. Gut 54: 388-95.
42. Jackson G.D.F., Lemaitre-Coelho I., Vaerman J.P., Bazin H., Beckers A. (1978) Rapid disappearance from serum of intravenously injected rat myeloma IgA and its secretion into bile. Eur J Immunol 8: 123-26.
43. Lemaître-Coelho I., Jackson G.D.F., Vaerman J.P. (1977) Rat bile as a convenient source of secretory IgA and free secretory component. Eur J Immunol 7: 588-90.
44. Lemaitre-Coelho I., Jackson G.D., Vaerman J.P. (1978) High levels of secretory IgA and free secretory component in the serum of rats with bile duct obstruction. J Exp Med 147: 934-9.
45. Palestrant D., Holzknecht Z.E., Collins B.H., Parker W., Miller S.E., Bollinger R.R. (2004) Microbial biofilms in the gut: visualization by electron microscopy and by acridine orange staining. Ultrastruct Pathol 28: 23-27.
46. Lewis K. (2007) Persister cells, dormancy and infectious disease. Nat Rev Micro 5: 48-56.
47. Lee S.M., Wyse A., Lesher A., Everett M.L., Lou L., Holzknecht Z.E., Whitesides J.F., Spears P.A., Bowles D.E., Lin S.S., Tonkonogy S.L., Orndorff P.E., Bollinger R.R., Parker W. (2010) Adaptation in a mouse colony monoassociated with Escherichia coli K-12 for more than 1, 000 days. Appl Environ Microbiol 76: 4655-63.
48. Reisner A., Krogfelt K.A., Klein B.M., Zechner E.L., Molin S. (2006) In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors. J Bacteriol 188: 3572-81.
49. Varga J.J., Therit B., Melville S.B. (2008) Type IV pili and the CcpA protein are needed for maximal biofilm formation by the gram-positive anaerobic pathogen Clostridium perfringens. Infect Immun 76: 4944-51.